We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Abingdon Health Plc | LSE:ABDX | London | Ordinary Share | GB00BLF79J41 | ORD 0.025P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | -4.76% | 10.00 | 9.50 | 10.50 | 10.00 | 10.00 | 10.00 | 64,378 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Chemicals & Chem Preps, Nec | 4.05M | -3.45M | -0.0284 | -3.52 | 12.17M |
From May 2021 to May 2024
TIDMABDX
RNS Number : 5337U
Abingdon Health PLC
03 December 2021
Abingdon Health plc
("Abingdon Health", the "Group" or the "Company")
Publication of Annual Report and Accounts and Notice of Annual General Meeting
York, U.K. 3 December 2021: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, is pleased to announce is pleased to announce that its Annual General Meeting ('AGM') will be held on Friday 24 December at 9.30 a.m. at the offices of Abingdon Health, York Biotech Campus, Sand Hutton, York, YO41 1LZ, United Kingdom.
Given the continued uncertainty relating to COVID-19, shareholders are encouraged to vote by proxy in advance of the AGM or appointing the chair of the meeting as their proxy.
The Company's Annual Report and Accounts for the year ended 30 June 2021 together with the notice convening the AGM and related form of proxy has been sent to shareholders and is available on the Company's website www.abingdonhealth.com.
Enquiries:
Abingdon Health plc www.abingdonhealth.com/investors/ Chris Yates, Chief Executive Officer Via Walbrook PR Melanie Ross , Chief Financial Officer Christopher Hand, Non-Executive Chairman Singer Capital Markets (Sole Broker and Tel: +44 (0)20 7496 3000 Nominated Adviser) Shaun Dobson, Peter Steel, Alex Bond (Corporate Finance) Tom Salvesen (Corporate Broking) Walbrook PR Limited Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com Paul McManus / Phillip Mob: +44 (0)7980 541 893 / +44 (0)7867 984 Marriage 082 Alice Woodings Mob: +44 (0)7407 804 654
About Abingdon Health
Abingdon Health is a world leading developer and manufacturer of high-quality rapid tests across all industry sectors, including healthcare and COVID-19. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and has also developed and marketed its own labelled tests.
The Company offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. This ability has a significant role to play in improving life across the world. To support this aim Abingdon Health has also developed AppDx(R) , a customisable image capturing technology that transforms a smartphone into a self-sufficient, standalone lateral-flow reader.
Founded in 2008, Abingdon Health is headquartered in York, England.
For more information visit: www.abingdonhealth.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACSBBBDDSGGDGBX
(END) Dow Jones Newswires
December 03, 2021 06:06 ET (11:06 GMT)
1 Year Abingdon Health Chart |
1 Month Abingdon Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
